Pharma Stocks
-
How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships
Royalty Pharma recently reported strong first-quarter 2026 results, highlighting double-digit growth in portfolio and royalty receipts and continued expansion of…
Read More » -
Which Pharma Stock Is the Better Buy?
Novo Nordisk NVO and Amgen AMGN are both global healthcare heavyweights with the scale, financial strength and research depth needed to…
Read More » -
CSPC PHARMA (01093.HK) Lansoprazole Enteric Capsules Receive Drug Registration Approval in China AASTOCKS Financial News
You expressly agree that the use of this app/website is at your sole risk. AASTOCKS.com Limited, HKEx Information Services Limited,…
Read More » -
We Think That There Are Issues Underlying Kwality Pharmaceuticals’ (NSE:KPL) Earnings
Unsurprisingly, Kwality Pharmaceuticals Limited’s (NSE:KPL) stock price was strong on the back of its healthy earnings report. However, our analysis…
Read More » -
A Look At Pharma Mar (BME:PHM) Valuation As Dividend Proposal Puts Shareholder Returns In Focus
Pharma Mar (BME:PHM) has proposed a dividend of €1.00 per share. This corporate action directly affects potential cash returns for…
Read More » -
Assessing Supernus Pharmaceuticals (SUPN) Valuation After Recent Share Price Weakness And Pipeline Progress
Recent performance context for Supernus Pharmaceuticals Without a single headline event driving attention today, Supernus Pharmaceuticals (SUPN) is on some…
Read More » -
Royalty Pharma (RPRX) Valuation Check After Strong Share Price Momentum And Royalty Growth Potential
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors…
Read More » -
MRK Stock Gains After CHMP Backs Keytruda Combo for Bladder Cancer
Shares of Merck MRK rose nearly 6% on Friday after the company announced that the EMA’s Committee for Medicinal Products…
Read More » -
Spotlight On Atea Pharmaceuticals And 2 Other Prominent Penny Stocks
Over the last 7 days, the market has risen 1.1%, with a notable 29% increase over the past year and…
Read More » -
Margin pressure, slower growth outlook may cap upside for Sun Pharma stock
ET Intelligence Group: Sun Pharmaceutical Industries recorded double-digit growth in revenue and net profit for the March quarter; however, operating…
Read More »